These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1388703)
21. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms. Arendt T; Brückner MK; Lange M; Bigl V Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164 [TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid cholinesterases--markers for loss of cholinergic basal forebrain neurons? Rossner S; Bakinde N; Zeitschel U; Schliebs R; Bigl V Int J Dev Neurosci; 1998; 16(7-8):669-73. PubMed ID: 10198815 [TBL] [Abstract][Full Text] [Related]
23. Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease. Elble R; Giacobini E; Scarsella GF Arch Neurol; 1987 Apr; 44(4):403-7. PubMed ID: 3827696 [TBL] [Abstract][Full Text] [Related]
24. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease. Mesulam MM; Asuncion Morán M Ann Neurol; 1987 Aug; 22(2):223-8. PubMed ID: 3662453 [TBL] [Abstract][Full Text] [Related]
25. The cholinergic system in Alzheimer's disease. Kása P; Rakonczay Z; Gulya K Prog Neurobiol; 1997 Aug; 52(6):511-35. PubMed ID: 9316159 [TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type. Tune L; Gucker S; Folstein M; Oshida L; Coyle JT Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585 [TBL] [Abstract][Full Text] [Related]
28. Cholinesterases and the pathology of Alzheimer disease. Geula C; Mesulam MM Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():23-8. PubMed ID: 8534419 [TBL] [Abstract][Full Text] [Related]
29. A review on cholinesterase inhibitors for Alzheimer's disease. Anand P; Singh B Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942 [TBL] [Abstract][Full Text] [Related]
30. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042 [TBL] [Abstract][Full Text] [Related]
31. Brain cholinesterases: I. The clinico-histopathological and biochemical basis of Alzheimer's disease. Shen ZX Med Hypotheses; 2004; 63(2):285-97. PubMed ID: 15236793 [TBL] [Abstract][Full Text] [Related]
35. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease. Sáez-Valero J; Sberna G; McLean CA; Small DH J Neurochem; 1999 Apr; 72(4):1600-8. PubMed ID: 10098867 [TBL] [Abstract][Full Text] [Related]
36. Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease. Kaerst L; Kuhlmann A; Wedekind D; Stoeck K; Lange P; Zerr I J Alzheimers Dis; 2014; 38(1):63-73. PubMed ID: 23948928 [TBL] [Abstract][Full Text] [Related]
37. Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Soininen H; Halonen T; Riekkinen PJ Acta Neurol Scand; 1981 Sep; 64(3):217-24. PubMed ID: 7315192 [TBL] [Abstract][Full Text] [Related]
38. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Lane RM; Potkin SG; Enz A Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515 [TBL] [Abstract][Full Text] [Related]
39. Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia. Wallin A; Sjögren M; Blennow K; Davidsson P Dement Geriatr Cogn Disord; 2003; 16(4):200-7. PubMed ID: 14512714 [TBL] [Abstract][Full Text] [Related]
40. Effect of long-term aluminum feeding on kinetics attributes of tissue cholinesterases. Dave KR; Syal AR; Katyare SS Brain Res Bull; 2002 Jun; 58(2):225-33. PubMed ID: 12127022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]